Pax-5 is a key regulator of the B cell-restricted expression of the CD23a isoform

European Journal of Immunology

Volumn 33, Issue 5, 2003, Pages 1163-1173

  Visan, Ioana ^a   Goller, Martin ^a,b   Berberich, Ingolf ^a   Kneitz, Christian ^a   Tony, Hans Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b GERMAN AEROSPACE CENTER DLR   (Germany)

Author keywords

B lymphocyte; CD23a; Gene regulation; Pax 5; Transcription factor

Indexed keywords

IMMUNOGLOBULIN E RECEPTOR; INTERLEUKIN 4; ISOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; BONE MARROW CELL; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVATION; GENE CONSTRUCT; GENE MUTATION; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM;

B-CELL-SPECIFIC ACTIVATOR PROTEIN; B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-4; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; RECEPTORS, IGE; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION FACTORS; U937 CELLS;

EID: 0038636287     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200323747     Document Type: Article

References (47)

1. Ikuta, K., Takami, M., Kim, C. W., Honjo, T., Miyoshi, T., Tagaya, Y., Kawabe, T. and Yodoi, J., Human lymphocyte Fc receptor for IgE: sequence homology of its cloned cDNA with animal lectins. Proc. Natl. Acad. Sci. U S A 1987. 84: 819-823.
2. Kikutani, H., Suemura, M., Owaki, H., Nakamura, H., Sato, R., Yamasaki, K., Barsumian, E. L., Hardy, R. R. and Kishimoto,T., Fc epsilon receptor, a specific differentiation marker transiently expressed on mature B cells before isotype switching. J. Exp. Med. 1986. 164: 1455-1469.
3. Delespesse, G., Suter, U., Mossalayi, D., Bettler, B., Sarfati, M., Hofstetter, H., Kilcherr, E., Debre, P. and Dalloul, A., Expression, structure, and function of the CD23 antigen. Adv. Immunol. 1991. 49: 149-191.
4. Yokota, A., Kikutani, H., Tanaka, T., Sato, R., Barsumian, E. L., Suemura, M. and Kishimoto, T., Two species of human Fc epsilon receptor II (Fc epsilon RII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell 1988. 55: 611-618.
5. Capron, M., Truong, M. J., Aldebert, D., Gruart, V., Suemura, M., Delespesse, G., Tourvieille, B. and Capron, A., Heterogeneous expression of CD23 epitopes by eosinophils from patients. Relationships with IgE-mediated functions. Eur. J. Immunol. 1991. 21: 2423-2429.
6. Dugas, B., Paul-Eugene, N., Coqueret, O., Mencia-Huerta, J. M. and Braquet, P., Possible role of CD23 in allergic diseases. Res. Immunol. 1992. 143: 448-451.
7. Karagiannis, S. N., Warrack, J. K., Jennings, K. H., Murdock, P. R., Christie, G., Moulder, K., Sutton, B. J. and Gould, H. J., Endocytosis and recycling of the complex between CD23 and HLA-DR in human B cells. Immunology 2001. 103: 319-331.
8. Kehry, M. R. and Yamashita, L. C., Low-affinity IgE receptor (CD23) function on mouse B cells: role in IgE-dependent antigen focusing. Proc. Natl. Acad. Sci. U S A 1989. 86: 7556-7560.
9. Pirron, U., Schlunck, T., Prinz, J. C. and Rieber, E. P., IgE-dependent antigen focusing by human B lymphocytes is mediated by the low-affinity receptor for IgE. Eur. J. Immunol. 1990. 20: 1547-1551.
10. Aubry, J. P., Pochon, S., Graber, P., Jansen, K. U. and Bonnefoy, J. Y., CD21 is a ligand for CD23 and regulates IgE production. Nature 1992. 358: 505-507.
11. Bjorck, P., Elenstrom-Magnusson, C., Rosen, A., Severinson, E. and Paulie, S., CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes. Eur. J. Immunol. 1993. 23: 1771-1775.
12. Sarfati, M., Chevret, S., Chastang, C., Biron, G., Stryckmans, P., Delespesse, G., Binet, J. L., Merle-Beral, H. and Bron, D., Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 1996. 88: 4259-4264.
13. Plater-Zyberk, C. and Bonnefoy, J. Y., Marked amelioration of established collagen-induced arthritis by treatment with antibodies to CD23 in vivo. Nat. Med. 1995. 1: 781-785.
14. Yokota, A., Yukawa, K., Yamamoto, A., Sugiyama, K., Suemura, M., Tashiro, Y., Kishimoto, T. and Kikutani, H., Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains. Proc. Natl. Acad. Sci. U S A 1992. 89: 5030-5034.
15. Dugas, B., Mossalayi, M. D., Damais, C. and Kolb, J. P., Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol. Today 1995. 16: 574-580.
16. Kolb, J. P., Abadie, A., Proschnicka-Chalufour, A., de Gramont, A. and Poggioli, J., CD23-mediated cell signalling. J. Lipid Mediat. Cell Signal. 1994. 9: 27-35.
17. Ewart, M. A., Ozanne, B. W. and Cushley, W., The CD23a and CD23b proximal promoters display different sensitivities to exogenous stimuli in B lymphocytes. Genes Immun. 2002. 3: 158-164.
18. Suter, U., Texido, G. and Hofstetter, H., Expression of human lymphocyte IgE receptor (Fc epsilon RII/CD23). Identification of the Fc epsilon RIIa promoter and its functional analysis in B lymphocytes. J. Immunol. 1989. 143: 3087-3092.
19. Kohler, I. and Rieber, E. P., Allergy-associated I epsilon and Ec epsilon receptor II (CD23b) genes activated via binding of an interleukin-4-induced transcription factor to a novel responsive element. Eur. J. Immunol. 1993. 23: 3066-3071.
20. Tinnell, S. B., Jacobs-Helber, S. M., Sterneck, E., Sawyer, S. T. and Conrad, D. H., STAT6, NF-kappa B and C/EBP in CD23 expression and IgE production. Int. Immunol. 1998. 10: 1529-1538.
21. Wang, F., Kikutani, H., Tsang, S. F., Kishimoto, T. and Kieff, E., Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 1991. 65: 4101-4106.
22. Fournier, S., Yang, L. P., Delespesse, G., Rubio, M., Biron, G. and Sarfati, M., The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Br. J. Haematol. 1995. 89: 373-379.
23. Hubmann, R., Schwarzmeier, J. D., Shehata, M., Hilgarth, M., Duechler, M., Dettke, M. and Berger, R., Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia. Blood 2002. 99: 3742-3747.
24. Adams, B., Dorfler, P., Aguzzi, A., Kozmik, Z., Urbanek, P., Maurer-Fogy, I. and Busslinger, M., Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 1992. 6: 1589-1607.
25. Barberis, A., Widenhorn, K., Vitelli, L. and Busslinger, M., A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev. 1990. 4: 849-859.
26. Nutt, S. L., Urbanek, P., Rolink, A. and Busslinger, M., Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 1997. 11: 476-491.
27. Nutt, S. L., Heavey, B., Rolink, A. G. and Busslinger, M., Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999. 401: 556-562.
28. Nutt, S. L., Eberhard, D., Horcher, M., Rolink, A. G. and Busslinger, M., Pax5 determines the identity of B cells from the beginning to the end of B-lymphopoiesis. Int. Rev. Immunol. 2001. 20: 65-82.
29. Czerny, T., Schaffner, G. and Busslinger, M., DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev. 1993. 7: 2048-2061.
30. Dorfler, P. and Busslinger, M., C-terminal activating and inhibitory domains determine the transactivation potential of BSAP (Pax-5), Pax-2 and Pax-8. EMBO J. 1996. 15: 1971-1982.
31. Kozmik, Z., Wang, S., Dorfler, P., Adams, B. and Busslinger, M., The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. Mol. Cell Biol. 1992. 12: 2662-272.
32. Nutt, S. L., Morrison, A. M., Dorfler, P., Rolink, A. and Busslinger, M., Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 1998. 17: 2319-2333.
33. Kishi, H., Wei, X. C., Jin, Z. X., Fujishiro, Y., Nagata, T., Matsuda, T. and Muraguchi, A., Lineage-specific regulation of the murine RAG-2 promoter: GATA-3 in T cells and Pax-5 in B cells. Blood 2000. 95: 3845-3852.
34. Reimold, A. M., Ponath, P. D., Li, Y. S., Hardy, R. R., David, C. S., Strominger, J. L. and Glimcher, L. H., Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1. J. Exp. Med. 1996. 183: 393-401.
35. Horcher, M., Souabni, A. and Busslinger, M., Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity. 2001. 14: 779-790.
36. Lindemann, D., Patriquin, E., Feng, S. and Mulligan, R. C., Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo. Mol. Med. 1997. 3: 466-476.
37. Goller, M., Kneitz, C., Mehringer, C., Muller, K., Jelley-Gibbs, D. M., Gosselin, E. J., Wilhelm, M. and Tony, H. P., Regulation of CD23 isoforms on B-chronic lymphocytic leukemia. Leukemia Res. 2002. 26: 795-802.
38. Kneitz, C., Goller, M., Tony, H., Simon, A., Stibbe, C., Konig, T., Serfling, E. and Avots, A., The CD23b promoter is a target for NF-AT transcription factors in B-CLL cells. Biochim. Biophys. Acta 2002. 1588: 41-47.
39. Ling, P. D., Hsieh, J. J., Ruf, I. K., Rawlins, D. R. and Hayward, S. D., EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. J. Virol. 1994. 68: 5375-5383.
40. Singh, M. and Birshtein, B. K., NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3′ alpha enhancer at early stages of B-cell differentiation. Mol. Cell Biol. 1993. 13: 3611-3622.
41. Rinkenberger, J. L., Wallin, J. J., Johnson, K. W. and Koshland, M. E., An interleukin-2 signal relieves BSAP (Pax5)-mediated repression of the immunoglobulin J chain gene. Immunity 1996. 5: 377-386.
42. Urbanek, P., Wang, Z. Q., Fetka, I., Wagner, E. F. and Busslinger, M., Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 1994. 79: 901-912.
43. Busslinger, M. and Urbanek, P., The role of BSAP (Pax-5) in B-cell development. Curr. Opin. Genet. Dev. 1995. 5: 595-601.
44. Zwollo, P., Arrieta, H., Ede, K., Molinder, K., Desiderio, S. and Pollock, R., The Pax-5 gene is alternatively spliced during B-cell development. J. Biol. Chem. 1997. 272: 10160-10168.
45. Higuchi, R., Krummel, B. and Saiki, R. K., A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Res. 1988. 16: 7351-7367.
46. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K. and Pease, L. R., Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 1989. 77: 51-59.
47. Soneoka, Y., Cannon, P. M., Ramsdale, E. E., Griffiths, J. C., Romano, G., Kingsman, S. M. and Kingsman, A. J., A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 1995. 23: 628-633.